Last reviewed · How we verify

NCT03776370

Preserving Left Colonic Artery During Radical Resection of Rectal Cancer

Completed Last updated 4 May 2022
What this trial tests

trial testing Preserve the left colonic artery in Postoperative Complications in 200 participants. Completed in 1 January 2022.

Timeline
1 December 2018
Primary endpoint
1 January 2022
1 January 2022

Quick facts

Lead sponsorThird Military Medical University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date1 December 2018
Primary completion1 January 2022
Estimated completion1 January 2022
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Third Military Medical University

Who can join

Adults 18 to 80, any sex, with Postoperative Complications or Proteinosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the feasibility and clinical significance of preserving left colonic artery in rectal cancer surgery.The investigators will focus on the effect of preserving left colonic artery during radical resection of rectal cancer on anastomotic leakage and oncology efficacy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Preservation versus nonpreservation of the left colic artery in anterior resection for rectal cancer: a propensity score-matched analysis.
    Zheng H, Li F, Xie X, Zhao S, et al · · 2022 · cited 12× · PMID 35538516 · DOI 10.1186/s12893-022-01614-y

Verify or expand the search:

Other recruiting trials for Postoperative Complications

Currently open trials in the same condition.

Other Third Military Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03776370.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing